-
Signature
-
/s/ Kristen Williams, Attorney-in-Fact
-
Stock symbol
-
PCRX
-
Transactions as of
-
May 31, 2023
-
Transactions value $
-
-$12,700
-
Form type
-
4
-
Date filed
-
6/2/2023, 06:28 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PCRX |
Common Stock |
Options Exercise |
$85K |
+2.5K |
+10.25% |
$34.00 |
26.9K |
May 31, 2023 |
Direct |
F1 |
| transaction |
PCRX |
Common Stock |
Sale |
-$97.7K |
-2.5K |
-9.23% |
$39.08 |
24.6K |
May 31, 2023 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PCRX |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2.5K |
-100% |
$0.00* |
0 |
May 31, 2023 |
Common Stock |
2.5K |
$34.00 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: